Note 8 - Commitments and Contingencies (Details Textual) - USD ($)				1 Months Ended		3 Months Ended		12 Months Ended
	Jul. 31, 2017	May 01, 2017	Mar. 21, 2017	Feb. 28, 2017	Jul. 31, 2015	Dec. 31, 2017	Sep. 30, 2017	Dec. 31, 2017	Dec. 31, 2016
Operating Leases, Rent Expense, Net								$ 175,552	$ 62,349
Contract Manufacturing Deposits, Current						$ 715,603		715,603
Former Acting Chief Financial Officer [Member]
Separation Agreement , Monthly Severance Payments	$ 12,500
Separation Agreement , Monthly Severance Payments, Period	1 year
Severance Costs							$ 150,000
Accrued Severance, Current						87,500		87,500
Master Services Agreement with Pharmaceutical Manufacturing Research Services Inc [Member] | Aspertec [Member]
Service Agreement, Term				5 years
Service Agreement, Estimated Cost of First Project				$ 2,800,000
Payments for Deposits								1,237,750
Contract Manufacturing Deposits, Current						445,625		$ 445,625
Investor Relations Agreement [Member]
Service Agreement, Term			1 year 90 days
Payments to Service Providers			$ 11,250
Service Agreement, Monthly Fee		$ 15,000
Service Agreement, Monthly Fee Payable in Cash		7,500
Service Agreement, Monthly Fee Payable in Common Stock		$ 7,500
Stock Issued During Period, Shares, Issued for Services								9,347
Lee's Pharmaceutical Holdings Limited [Member]
Royalty Revenue						200,000
Proceeds from Royalties Received					$ 200,000
Assets Leased to Others [Member]
Assets Disposed of by Method Other than Sale, in Period of Disposition, Gain (Loss) on Disposition						(200,000)
Operating Leases, Future Minimum Payments Receivable						$ 784,000		$ 784,000